These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3665963)

  • 1. Epidemiology and prevention of cardiac failure: Framingham Study insights.
    Kannel WB
    Eur Heart J; 1987 Sep; 8 Suppl F():23-6. PubMed ID: 3665963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and risk profile of cardiac failure.
    Kannel WB; Cupples A
    Cardiovasc Drugs Ther; 1988 Nov; 2 Suppl 1():387-95. PubMed ID: 3154646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and epidemiology of heart failure.
    Kannel WB
    Heart Fail Rev; 2000 Jun; 5(2):167-73. PubMed ID: 16228142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study.
    Haider AW; Larson MG; Franklin SS; Levy D;
    Ann Intern Med; 2003 Jan; 138(1):10-6. PubMed ID: 12513039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological aspects of heart failure.
    Kannel WB
    Cardiol Clin; 1989 Feb; 7(1):1-9. PubMed ID: 2523239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and risk profile of cardiac failure.
    Kannel WB; Cupples A
    Cardiovasc Drugs Ther; 1988 Nov; 2(Suppl 1):387-395. PubMed ID: 27722843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status.
    Schatzkin A; Cupples LA; Heeren T; Morelock S; Kannel WB
    Am J Epidemiol; 1984 Dec; 120(6):888-99. PubMed ID: 6239541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The progression from hypertension to congestive heart failure.
    Levy D; Larson MG; Vasan RS; Kannel WB; Ho KK
    JAMA; 1996 May 22-29; 275(20):1557-62. PubMed ID: 8622246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of heart failure.
    Kannel WB; Belanger AJ
    Am Heart J; 1991 Mar; 121(3 Pt 1):951-7. PubMed ID: 2000773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study.
    Kannel WB; Levy D; Cupples LA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S135-40. PubMed ID: 2485019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure.
    Kannel WB
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():199-212. PubMed ID: 9211012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
    Okin PM; Devereux RB; Nieminen MS; Jern S; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Dahlöf B;
    Circulation; 2006 Jan; 113(1):67-73. PubMed ID: 16365195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime risk for developing congestive heart failure: the Framingham Heart Study.
    Lloyd-Jones DM; Larson MG; Leip EP; Beiser A; D'Agostino RB; Kannel WB; Murabito JM; Vasan RS; Benjamin EJ; Levy D;
    Circulation; 2002 Dec; 106(24):3068-72. PubMed ID: 12473553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study.
    D'Agostino RB; Belanger AJ; Kannel WB; Cruickshank JM
    BMJ; 1991 Aug; 303(6799):385-9. PubMed ID: 1912805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis after initial myocardial infarction: the Framingham study.
    Kannel WB; Sorlie P; McNamara PM
    Am J Cardiol; 1979 Jul; 44(1):53-9. PubMed ID: 453046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden death: lessons from subsets in population studies.
    Kannel WB; Schatzkin A
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):141B-149B. PubMed ID: 3889106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Need and prospects for prevention of cardiac failure.
    Kannel WB
    Eur J Clin Pharmacol; 1996; 49 Suppl 1():S3-9. PubMed ID: 8834926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of sudden coronary death: population at risk.
    Kannel WB; Gagnon DR; Cupples LA
    Can J Cardiol; 1990 Dec; 6(10):439-44. PubMed ID: 2148709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.
    He J; Ogden LG; Bazzano LA; Vupputuri S; Loria C; Whelton PK
    Arch Intern Med; 2001 Apr; 161(7):996-1002. PubMed ID: 11295963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epidemiological perspective of sudden death. 26-year follow-up in the Framingham Study.
    Kannel WB; McGee DL; Schatzkin A
    Drugs; 1984 Oct; 28 Suppl 1():1-16. PubMed ID: 6499693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.